Swiss Go Trial Group

This Swiss study is testing whether personalized treatment recommendations can help patients with a specific type of ovarian cancer. Doctors will analyze each patient's tumor to suggest the most suitable drugs, which may differ from standard chemotherapy. The trial will compare o…

This large Phase 3 trial is testing whether adding the drug letrozole to standard maintenance therapy helps prevent ovarian cancer from coming back. It will involve 540 women with ER-positive ovarian, fallopian tube, or peritoneal cancer who have completed initial surgery and che…

This study aims to understand the connection between specific signs seen on ultrasound scans and the severity of symptoms in women with adenomyosis, a common but often underdiagnosed uterine condition. Researchers will enroll 1000 pre- and perimenopausal women, both with and with…